Elosulfase alfa

Vimizim 1 mg/ml concentraat voor oplossing voor infusie

Concentraat voor oplossing voor infusieNetherlandsAuthorisedAuthorised 28 Apr 2014

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

VimizimEuropean UnionAuthorised

VimizimCanada · 1 MG / ML · Solution · Biomarin International LimitedSame brand
Vimizim 1MG/ML Concentrado Para Solucion Para PerfusionSpain · 5 mg · concentrado para solución para perfusión · Biomarin International LimitedSame brand
VimizimEuropean Union · BioMarin International LimitedSame brand
VimizimCroatiaSame brand
VimizimItaly · Concentrato per soluzione per infusione · Biomarin International LimitedSame brand
VIMIZIM 1 mg/mlRomania · 1mg/ml · conc. pt. sol. perf. · Biomarin International Limited

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Elosulfase alfa

Vimizim 1 mg/ml concentraat voor oplossing voor infusie

Concentraat voor oplossing voor infusieNetherlandsAuthorisedAuthorised 28 Apr 2014

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

VimizimEuropean UnionAuthorised

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

VIMIZIM 1mg/mlRomania · 1mg/ml · conc. pt. sol. perf. · Biomarin Europe Limited

Vimizim®Serbia · 1mg/mL · koncentrat za rastvor za infuziju · Evropa Lek Pharma D.O.O. Beograd

VimizimUnited States · 5MG/5ML · injectable · Biomarin Pharm

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

College ter Beoordeling van Geneesmiddelen

College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.

Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim · Added 8 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Elosulfase alfa
Dosage form: Concentraat voor oplossing voor infusie
Route: Intraveneus gebruik
Register: Netherlands (CBG-MEB)
Status: Authorised
Status in the register: Ingeschreven
Authorised: 28 Apr 2014
Registration: EU/1/14/914
Marketing authorisation holder: BioMarin International Limited
ATC code: A16AB12
Group: Alimentary tract and metabolism
Procedure: EU centralised
Supply: Uitsluitend recept
EMA product number: EMEA/H/C/002779
EU number: EU/1/14/914